Skip to content

Clinical trials

Phase 3 Erythema trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Erythema Phase: Phase 3 Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20121
20131
20143
20171
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Allergan3
Galderma R&D3
Assistance Publique - Hôpitaux de Paris1
Faes Farma, S.A.1
Goldman, Butterwick, Fitzpatrick and Groff1
Memorial University of Newfoundland1
Padagis LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Erythema11
Rosacea6
Bronchiolitis Obliterans Syndrome1
Erythema Multiforme1
Fever1
Hypersensitivity, Immediate1
Infections1
Leukocytosis1
Sepsis1
Skin Diseases, Vascular1

Trials

Showing 76 to 11 of 11. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.